National Research's 15min chart shows KDJ Golden Cross, Bullish Marubozu Pattern.

National Research's 15-minute chart has recently triggered a KDJ Golden Cross and a Bullish Marubozu at 08/19/2022 15:30, indicating a shift in the momentum of the stock price towards an upward trend. This suggests that the stock has the potential to continue its upward trajectory and may experience further increases in value. The presence of buyers in control of the market is also a bullish indicator, and it is likely that the positive momentum will continue.

National Research Corporation (NRC) has recently experienced a significant shift in its stock price momentum, as indicated by a bullish signal on its 15-minute chart. On August 19, 2022, at 15:30, the stock exhibited a KDJ Golden Cross and a Bullish Marubozu pattern, signaling a potential upward trend [1].

The KDJ Golden Cross, generated by the KDJ indicator, occurs when the K line crosses above the D line, often signaling a bullish trend. The Bullish Marubozu candlestick pattern is characterized by a long body with no shadows above or below, indicating strong buying pressure. These indicators follow a broader trend of narrowing Bollinger Bands and KDJ Death Cross formations observed in other stocks such as ASGN and Cushing NextGen [2].

While these technical indicators provide valuable insights, investors should consider them alongside fundamental analysis and broader market conditions. Several analyst ratings and price targets have been updated recently, offering additional insights into the potential performance of various stocks. As of July 7, 2025, notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts [3].

Positive Outlook:
- Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [3].
- Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [3].
- CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [3].
- Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [3].
- Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [3].
- Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [3].
- Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [3].
- Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [3].
- JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [3].
- Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [3].
- Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [3].
- MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [3].
- Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [3].
- Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [3].
- Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [3].
- Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [3].
- Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [3].
- Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [3].
- Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [3].
- Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [3].
- PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [3].
- Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [3].

References:
[1] https://www.ainvest.com/news/national-research-15min-chart-shows-kdj-golden-cross-bullish-marubozu-2508/
[2] https://www.ainvest.com/news/national-research-15min-chart-shows-kdj-golden-cross-bullish-marubozu-2508/
[3] https://www.ainvest.com/news/equity-bancshares-15min-chart-sees-kdj-golden-cross-bullish-marubozu-indicator-2508-93/